CAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.289800E-01
Normal-vs-Stage2
8.848400E-01
Normal-vs-Stage3
2.934200E-01
Normal-vs-Stage4
7.742400E-01
Stage1-vs-Stage2
4.585800E-01
Stage1-vs-Stage3
7.821800E-01
Stage1-vs-Stage4
5.057200E-01
Stage2-vs-Stage3
2.825000E-01
Stage2-vs-Stage4
6.224000E-01
Stage3-vs-Stage4
2.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.544200E-01
Normal-vs-AfricanAmerican
4.453800E-01
Normal-vs-Asian
8.507200E-01
Caucasian-vs-AfricanAmerican
6.524200E-01
Caucasian-vs-Asian
7.753800E-01
AfricanAmerican-vs-Asian
5.053600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.116200E-01
Normal-vs-Female
7.103600E-01
Male-vs-Female
8.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.588000E-01
Normal-vs-Age(41-60Yrs)
8.842200E-01
Normal-vs-Age(61-80Yrs)
6.862000E-01
Normal-vs-Age(81-100Yrs)
7.030100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.078600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.162000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.828600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.296300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.744750E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.765500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.163600E-01
Normal-vs-Daily Drinker
4.666800E-01
Normal-vs-Weekly Drinker
5.517000E-01
Normal-vs-Occasional Drinker
9.802200E-01
Normal-vs-Social Drinker
6.012200E-01
Non Drinker-vs-Daily Drinker
4.366400E-01
Non Drinker-vs-Weekly Drinker
5.129600E-01
Non Drinker-vs-Occasional Drinker
8.190500E-02
Non Drinker-vs-Social Drinker
4.716200E-01
Daily Drinker-vs-Weekly Drinker
8.458800E-01
Daily Drinker-vs-Occasional Drinker
5.789600E-01
Daily Drinker-vs-Social Drinker
8.804000E-01
Weekly Drinker-vs-Occasional Drinker
3.827800E-01
Weekly Drinker-vs-Social Drinker
9.550600E-01
Occasional Drinker-vs-Social Drinker
4.164400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.393200E-01
Normal-vs-Grade 2
7.172000E-02
Normal-vs-Grade 3
1.071400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.410100E-04
Grade 1-vs-Grade 3
6.935200E-03
Grade 1-vs-Grade 4
5.393200E-01
Grade 2-vs-Grade 3
3.920400E-01
Grade 2-vs-Grade 4
7.172000E-02
Grade 3-vs-Grade 4
1.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.921000E-01
Normal-vs-NonDiabetic
7.692200E-01
Diabetic-vs-NonDiabetic
5.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.279000E-01
Normal-vs-NoPancreatitis
7.037000E-01
Pancreatitis-vs-NoPancreatitis
1.582420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.706000E-01
Normal-vs-N1
8.533000E-01
N0-vs-N1
4.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.305800E-01
Normal-vs-TP53-NonMutant
2.363300E-03
TP53-Mutant-vs-TP53-NonMutant
3.14859999994699E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
